NASDAQ$BTTC

Black Titan Corp · Q4 2013 earnings

Q4 2013 earnings · · Investor relations

Headline financials

Total Revenue

$911K

Previous: $3.26M-72.0%
EPS (adj)

-$2.33

Previous: -$3.18+26.9%
Net Income

-$209K

Previous: -$279K+25.1%
Operating Income

-$642K

Previous: -$441K-45.6%
Gross Profit

-$18K

Previous: $686K-102.6%
R&D Expense

$929K

Previous: $2.57M-63.9%

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$911K

Q4 2013-72%vs Q4 2012
Beat estimate in 3 of 3 quarters(100%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro